Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms [Phase 3]
The Phase 3 trial evaluating zoledronic acid (zoledronate) with standard therapy versus placebo with standard therapy in asymptomatic recurr…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy [Phase 2]
Phase 2 clinical trial of dutasteride for recurrent prostate cancer unresponsive to androgen-deprivation therapy has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer [Phase 2]
Phase 2 clinical trial update for ZD4054 in prostate cancer; study terminated with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 [Phase 1]
An expanded access study of Abiraterone Acetate for advanced prostate cancer has completed after COU-AA-001.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 3]
A Phase 3 trial evaluated adding bevacizumab to docetaxel and prednisone in men with hormone-refractory prostate cancer; results were posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer [Phase 1]
A Phase 1 pharmacokinetics study comparing abiraterone acetate capsule and tablet formulations in patients with prostate cancer has complete…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer [Phase 2]
The document reports the completion of a Phase 2 trial evaluating the safety and efficacy of abiraterone acetate in men with prostate cancer…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Early Stage Prostate Cancer Cohort
This clinical trial update notes that the early-stage prostate cancer cohort has completed. The trial is listed as status COMPLETED.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) [Phase 2]
A Phase 2 study evaluating CP-751,871 in combination with docetaxel and prednisone in hormone-insensitive prostate cancer has completed and …
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating quinacrine in androgen-independent prostate cancer has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer [Phase 3]
This clinical trial update reports on a Phase 3 comparison of long-acting versus short-acting LHRH agonists in the treatment of prostate can…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial evaluating docetaxel plus a phytochemical for hormone-independent metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]
Phase 1 study of Alvespimycin hydrochloride in patients with metastatic or unresectable solid tumors has been completed, evaluating safety a…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Satraplatin and Prednisone to Treat Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating satraplatin plus prednisone for prostate cancer has completed; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies [NA]
This clinical trial compared transrectal ultrasonography-guided saturation biopsy with a 10-12 core biopsy in men undergoing repeat prostate…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy [Phase 2]
A completed Phase 2 trial evaluating dolastatin-10 in patients with metastatic prostate cancer that did not respond to prior hormone therapy…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluated adding isoflavones to radiation therapy for localized prostate cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer [Phase 2, Phase 3]
This completed Phase 2/3 randomized trial compared seminal vesicle-sparing prostatectomy with nerve-sparing radical prostatectomy in men wit…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer [Phase 2]
Phase II study evaluating PROSTVAC-V and PROSTVAC-F vaccines with GM-CSF in prostate cancer patients with PSA progression after local therap…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Biological Therapy in Treating Patients With Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating a biological therapy for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Vinflunine in Hormone Refractory Prostate Cancer (HRPC) [Phase 2]
Phase 2 clinical trial update for vinflunine in hormone-refractory prostate cancer has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy [Phase 2]
A Phase 2 trial evaluated the combination of docetaxel, estramustine, and thalidomide in men with prostate cancer previously treated with ho…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer [Phase 3]
This document reports on a Phase 3 trial comparing early versus delayed hormone therapy in nonmetastatic prostate cancer. The trial status i…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer [Phase 3]
Phase 3 study evaluating cyproterone acetate for hot flashes after surgical or chemical castration in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer [Phase 1]
Phase 1 trial evaluating a vaccine therapy plus QS21 in prostate cancer has completed.